Nivolumab/
Medically reviewed by Drugs.com. Last updated on Mar 18, 2022.
Commonly used brand name(s)
In the U.S.
- Opdualag
Available Dosage Forms:
- Solution
Therapeutic Class: Antineoplastic Agent
Pharmacologic Class: Monoclonal Antibody
Uses for nivolumab/relatlimab-rmbw
Nivolumab and relatlimab-rmbw combination injection is used to treat melanoma (skin cancer) that has spread throughout the body (metastatic) or that cannot be removed by surgery.
Nivolumab/relatlimab-rmbw is to be given only by or under the supervision of your doctor.
Before using nivolumab/relatlimab-rmbw
In deciding to use a medicine, the risks of taking the medicine must be weighed against the good it will do. This is a decision you and your doctor will make. For nivolumab/relatlimab-rmbw, the following should be considered:
Allergies
Tell your doctor if you have ever had any unusual or allergic reaction to nivolumab/relatlimab-rmbw or any other medicines. Also tell your health care professional if you have any other types of allergies, such as to foods, dyes, preservatives, or animals. For non-prescription products, read the label or package ingredients carefully.
Pediatric
Appropriate studies performed to date have not demonstrated pediatric-specific problems that would limit the usefulness of nivolumab and relatilimab-rmbw combination injection in children 12 years of age and older weighing at least 40 kilograms (kg). Safety and efficacy have not been established in children 12 years of age and older weighing less than 40 kg, and in children younger than 12 years of age.
Geriatric
Appropriate studies performed to date have not demonstrated geriatric-specific problems that would limit the usefulness of nivolumab and relatilimab-rmbw combination injection in the elderly.
Breastfeeding
There are no adequate studies in women for determining infant risk when using this medication during breastfeeding. Weigh the potential benefits against the potential risks before taking this medication while breastfeeding.
Interactions with medicines
Although certain medicines should not be used together at all, in other cases two different medicines may be used together even if an interaction might occur. In these cases, your doctor may want to change the dose, or other precautions may be necessary. When you are receiving nivolumab/relatlimab-rmbw, it is especially important that your healthcare professional know if you are taking any of the medicines listed below. The following interactions have been selected on the basis of their potential significance and are not necessarily all-inclusive.
Using nivolumab/relatlimab-rmbw with any of the following medicines is usually not recommended, but may be required in some cases. If both medicines are prescribed together, your doctor may change the dose or how often you use one or both of the medicines.
- Tofacitinib
Interactions with food/tobacco/alcohol
Certain medicines should not be used at or around the time of eating food or eating certain types of food since interactions may occur. Using alcohol or tobacco with certain medicines may also cause interactions to occur. Discuss with your healthcare professional the use of your medicine with food, alcohol, or tobacco.
Other medical problems
T...
